We produced anti-idiotype antibodies to antibody to lipid A from Eikenella corrodens. The ALA-1 monoclonal antibody (immunoglobulin M [IgM] isotype), which had already been produced in our laboratory (T. Kato, I. Takazoe, and K. Okuda, Infect. Immun. 57:656-659, 1989), had reacted strongly with lipid A from E. corrodens, Escherichia coli, and Salmonella minnesota. Four anti-idiotype monoclonal antibodies to ALA-1 (Abl), designated A2LA-1 (IgGl isotype), A2LA-2 (IgG2a isotype), A2LA-3 (IgG2a isotype), and A2LA-4 (IgG3 isotype), which recognized the idiotype Abl, were produced. A2LA-1, A2LA-2, and A2LA-3 were capable of over 61% inhibition of ALA-1 reactivity to E. coli J5 lipid A in an enzyme-linked immunosorbent assay system. The sera of mice and rabbits immunized with the anti-idiotype antibodies revealed that the internal image anti-idiotype antibody induced the production of IgG antibodies that cross-reacted with or bound to lipid A. These studies indicate that A2LA-1 and A2LA-2 contained an antigenic epitope that mimicked lipid A. Immunization of mice with A2LA-1 resulted in prevention of lethal toxicity from E. coli J5 lipopolysaccharide.
The lipid A component represents the biologically active principle of lipopolysaccharide (LPS), and free lipid A shows most of the endotoxic activities of LPS (8, 16, 30) . Eikenella corrodens is a microaerophilic, gram-negative rod isolated from periodontal pockets of humans with periodontitis (24, 33, 35) . The LPS from this species has been found to have fairly strong classical endotoxic activities (1, 17, 29, 32) . We produced monoclonal antibodies (designated ALA-1, ALA-2, ALA-3, and ALA-4) that recognized the lipid A of E. corrodens (12) . These monoclonal antibodies, which were immunoglobulin M (IgM) isotypes, reacted strongly with lipid A from Escherichia coli and Salmonella minnesota as well as E. corrodens.
The immune response to LPS antigens differs from the response to protein antigens. For example, LPS is a thymusindependent antigen that cannot receive full T-cell help (5) . T-cell-independent LPS antigens fail to elicit a sufficient IgG immune response and induce endotoxin-neutralizing antibody. A strategy for the conversion of the thymus-independent polysaccharide into a thymus-dependent immunogen is to develop a surrogate image of the polysaccharide at the combining site of an anti-idiotype antibody (15) . In this report, we describe the development of a monoclonal antiidiotype antibody (Ab2) that induced protective antibodies in mice against lethal toxicity of LPS to a monoclonal antibody (Abl) that recognized the lipid A epitope ( (12) and was therefore selected as idiotype Abl. Large quantities of the antibody were produced by intraperitoneal injection of hybridoma cells into pristane-treated BALB/c mice. After 10 to 14 days, the ascites, containing high concentrations of antibodies, was harvested. The spleens of these ascitic mice were removed and used for the production of monoclonal anti-idiotype antibodies (Ab2). The spleen cells were fused with SP2/o Agl4 myeloma cells as described previously (23) . Culture supernatants were screened for production of IgG monoclonal anti-idiotype antibody by an enzyme-linked immunosorbent assay (ELISA) with the ALA-1 antibody (isotype IgM) as the coating antigen. The positive hybridomas were cloned by limiting dilution. To determine the isotypes of murine monoclonal antibodies, immunodiffusion was carried out in 0.9% agarose in phosphate-buffered saline (PBS; pH 7.2) by the method of Ouchterlony (27) .
Preparation of lipid A. The LPS of E. corrodens FDC 375, extracted by the hot phenol-water method (38) , were treated with 1% acetic acid at 100°C for 30 min (9). The crude lipid A was collected by centrifugation and washed with distilled water. LPS from E. coli J5 was purchased from List Biological Laboratories, Campbell, Calif. Lipid A from E. coli J5 was purchased from RIBI Immunochem Research Inc., Hamilton, Mont.
ELISA. The ALA series of monoclonal antibodies, ECF-1, and ECF-2 antibodies recognized the core epitope of E. corrodens LPS (12) added to each well, and plates were incubated for 1 h at 37°C and washed three times with PBS-0.05% Tween 20. The plates were incubated for 1 h with peroxidase-conjugated anti-mouse IgG (Cappel Laboratories, Cochranville, Pa.), washed three times, and developed with 200 ,ul of o-phenylenediamine dihydrochloride (Wako Pure Chemical Industries, Ltd., Osaka, Japan) substrate.
ELISA inhibition tests. In the inhibition studies, Abl culture supernatant diluted 1:10 was incubated with Ab2 ascites for 1 h at 37°C. MSA257 monoclonal antibody (IgGl isotype), which reacted with 34,000-dalton antigens of Treponema denticola strains, was also used as control ascites (6) . The mixture was centrifuged at 18,500 x g for 30 min to pellet Abl-Ab2 complexes and tested for its ability to react with lipid A of E. coli J5 (RIBI Immunochem Research) in an ELISA system. Lipid A of E. coli J5 was diluted in PBS to a final concentration of 10 ,ug/ml.
To determine whether monoclonal anti-idiotype antibodies (Ab2) could bind to polymyxin B, which is known to bind to lipid A (22), ELISA inhibition tests were carried out by adding polymyxin B (1, 10, 25, 50, and 100 U/ml) to plates coated with Ab2 antibodies (10 ,ug/ml). After 1 h of incubation at 37°C, the unbound polymyxin B was removed and the ALA-1 (Abl) antibody was added. The remainder of the assay was done as described above.
The 
RESULTS
Development of the anti-idiotype antibodies. Hybridomas of the anti-idiotype antibody (Ab2) that might have the surrogate image of the lipid A epitope as their combining site were screened for recognition of ALA-1 (Abl) monoclonal antibody in an ELISA. Four anti-idiotype monoclonal antibodies that reacted with the ALA-1 antibody, designated A2LA-1, A2LA-2, A2LA-3, and A2LA-4, were finally obtained. A2LA-1 was an IgGl isotype, A2LA-2 and A2LA-3 were IgG2a isotypes, and A2LA-4 was an IgG3 isotype. A2LA-1, A2LA-2, and A2LA-3 monoclonal antibodies reacted with ALA-1, ALA-2, ALA-3, and ALA-4 IgM antibodies, but not with the ECF series of IgM antibodies, which recognized the core region of E. corrodens LPS (Table 1) . The A2LA-4 antibody showed low reactivity with the ECF series of antibodies. No A2LA series of antibodies reacted with purified mouse IgM antigen (Chemicon International Inc., Los Angeles, Calif.).
ELISA inhibition tests. The four anti-idiotype antibodies that recognized the idiotype Abl were tested for their ability to inhibit ALA-1 reactivity to lipid A of E. coli in an ELISA system. A2LA-1, A2LA-2, and A2LA-3 antibodies (100 ,ug/ml) showed 61 to 73% inhibition of ALA-1 reactivity ( Table 2 ). A2LA-4 antibody failed to inhibit ALA-1 reactivity. These studies suggested that A2LA-1, A2LA-2, and A2LA-3 monoclonal antibodies might be expressing an epitope closely related to or immunologically identical to the lipid A from gram-negative bacterial LPS. We found that 100 U of polymyxin B per ml inhibited the binding activities of ALA-1 antibody to A2LA-1, A2LA-2, and A2LA-3 antibodies (71 to 91% inhibition) but did not inhibit the reactivity of A2LA-4 antibody (Table 3) . These results suggest a similarity of structures between the paratopes of A2LA-1, A2LA-2, and A2LA-3 (but not A2LA-4) and epitopes of lipid A.
Mouse and rabbit immunizations with A2LA-1 and A2LA-2. The abilities of A2LA-1 and A2LA-2 to generate anti-lipid A immune responses in mice and rabbits were studied. The sera of the mice and the rabbits immunized with A2LA-1 or A2LA-2 revealed an anti-E. coli J5 lipid A IgG antibody response (Fig. 1) . No serum of unimmunized mice or rabbits contained anti-lipid A antibodies. These results indicated that A2LA-1 and A2LA-2 contained an antigenic epitope that mimicked lipid A. A2LA-1 and A2LA-2 functioned as effective immunogens and stimulated an anti-lipid A IgG antibody response in mice and rabbits.
Prevention of lethal toxicity of E. coli J5 LPS. Twenty micrograms of E. coli J5 LPS was highly lethal when injected intraperitoneally into galactosamine-sensitized mice (Table  4 ). The protective efficacy of A2LA-1 immunization to BALB/c and ddY mice against 20 ,ug of E. coli J5 LPS injection is shown in Table 4 . Almost all (13 of 14) control mice died by 2 days after injection of 20 ,ug of LPS, whereas 82 to 100% of the mice survived in the group given A2LA-1 anti-idiotype antibody. The survivors did not die during the monitoring period (10 weeks (13-15, 20, 34) . One approach to converting T-cell-independent antigens into T-cell-dependent antigens is to utilize anti-idiotype antibodies. Previously we described monoclonal antibodies that reacted with the lipid A of E. corrodens LPS (12) . One of these monoclonal antibodies, ALA-1, which reacted strongly with lipid A preparations from E. coli and S. minnesota as well as E. corrodens, was selected to produce the anti-idiotype antibody. Anti-idiotype antibodies, which serve as surrogates for the nominal antigen, are capable of competing with the nominal antigen for the binding site and are called Ab2 beta (2). In the present study, we showed that three of four anti-idiotype antibodies against monoclonal antibodies to the lipid A from E. corrodens LPS inhibited the binding site of the nominal antigen in an inhibition ELISA. These results suggest that these three antibodies recognized an idiotypic determinant very close to, if not identical with, the paratopic regions of the combining site. The reactivities of the three anti-idiotype antibodies were inhibited by polymyxin B. Furthermore, KLH-conjugated A2LA-1 and A2LA-2 antibodies evoked an IgG antibody response specific for the lipid A of E. coli J5 in mice (syngenic species) and rabbits (xenogenic species). When an ELISA was carried out with lipid A of E. corrodens FDC 375 as the coating antigen, the antisera from animals immunized with A2LA-1 and A2LA-2 also exhibited high reactivities (data not shown). These results indicate that A2LA-1 and A2LA-2 antibodies are Ab2 beta. A2LA-1 and A2LA-2 contained a surrogate image on the combining site that mimicked a lipid A epitope common to LPSs from E. corrodens and E. coli. The common epitope perhaps included the D-glucosamine backbone component of lipid A, because the reactivity of ALA-1 and lipid A was inhibited by D-glucosamine (12) .
It was expected that antiserum against LPS would counteract the lethal effects of the endotoxin (36) . Successful broad-spectrum protection against challenge by several gram-negative bacteria or LPSs in different animal models has been demonstrated (3, 4, 18, 19, 39). However, controversy exists as to the nature and specificity of protection afforded by antisera induced by using rough mutants as immunogens (10, 25, 28, 31, 37) . Although it is known that most of the biological activity of endotoxin resides in the lipid A moiety of the LPS molecule, the fine specificity of the protective antibodies in the antiserum is difficult to ascertain. Immunization of BALB/c and ddY mice with A2LA-1 resulted in prevention of lethal toxicity of E. coli J5 LPS. Anti-idiotype A2LA-1 monoclonal antibody, which mimicked the lipid A epitope, is capable of evoking antibodies that prevent the lethal toxicity of LPS.
In conclusion, we succeeded in producing anti-idiotype antibodies that were the surrogate image of a lipid A epitope among LPSs common to E. corrodens and E. coli. The anti-idiotype antibodies to anti-lipid A antibodies were useful for inducing endotoxin-neutralizing antibody. 1977. Antibody to cell wall glycolipid of gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. J. Infect. Dis. 136:S167-S173.
